Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
330.60    -4.80 (-1.43%)
Bid:
331.00
Ask:
333.40
Spread: 2.40 (0.725%)
Market Cap: £724.24m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Trading Update

24 Jan 2013 07:00

RNS Number : 2487W
Burford Capital
24 January 2013
 



 

 

24 January 2013

 

BURFORD CAPITAL REPORTS SIGNIFICANT PROGRESS IN 2012

 

Record Year For Investment Recoveries

 

Burford Capital Limited ("Burford" or the "Company") is pleased to provide the following update on 2012 activity in advance of the release of its audited financial statements. The information in this IMS is as of 31 December 2012 and covers the fiscal year 2012.1

 

Summary

 

Burford demonstrated strong performance in 2012 with significant investment progress and a real maturation of the business. Neither Burford nor litigation finance is nascent any longer: Burford has evolved into a full-fledged, internally managed finance and investment business with multiple lines of business, multi-jurisdictional operations and compelling returns.

 

In 2012:

·; Burford generated investment recoveries of $47 million on a gross basis and $18 million net of invested capital - a 61% net return on invested capital

·; At year-end, a further $53 million in gross investment recoveries and $19 million in net investment recoveries were pending - a 55% net return on invested capital

·; Firstassist also performed strongly and contributed $11 million of EBITDA for its ten months in 2012 under Burford's ownership; Firstassist's overall 2012 performance was more than 35% ahead of the prior year

·; Burford also generated a further $9 million in net income from its portfolio financing and cash management activities

·; Burford continued active investing in 2012 based on its strong pipeline, making $72 million in new commitments to nine new investments

 

Since inception:

·; Burford has generated investment recoveries of $93 million on a gross basis and $35 million net of invested capital - a 61% net return on invested capital

·; Including pending matters, Burford stands at $147 million in gross investment recoveries and $54 million in net investment recoveries - a 59% net return on invested capital

·; Burford has committed $373 million to investments

 

Investment portfolio performance

 

Burford experienced material portfolio activity in 2012 that demonstrated the quality of its investment decisions and the vibrancy of its investment model. While the majority of Burford's investments have yet to reach maturity and contribute to performance, a significant minority of investments has now shown results and Burford has achieved consistent returns on invested capital of approximately 60%, net of losses and before operating expenses. Burford looks forward to 2013, when it expects further substantial portfolio activity.

 

Since inception, 18 investments have generated $93 million in gross investment recoveries 2 and $35 million net of invested capital, producing a 61% net return on invested capital.

 

In 2012 alone, 12 investments produced $47 million in gross investment recoveries and $18 million net of invested capital - likewise a 61% net return on invested capital. The acceleration in portfolio activity in 2012 is noteworthy: 2012 alone produced as much in investment recoveries as the two preceding years combined.

 

In addition to those investment recoveries, Burford has seven investments where trial or some initial adjudication has been completed but further proceedings remain, such as an appeal. If all such investments produce investment recoveries at the level awarded following trial or initial adjudication, Burford would have received at 31 December 2012 an additional $53 million in gross investment recoveries and $19 million net of invested capital - a 55% net return on invested capital.

 

All of the foregoing figures are net of investment losses and before operating expenses, including, in the case of the immediately preceding paragraph, losses that remain subject to appeal or further proceedings. As Burford has commented before, losses are an expected and inevitable aspect of our portfolio approach to litigation investing.

 

We make special mention of the Arizona real estate matter first announced in 2010. Matters have now progressed and, in short, Burford expects to generate a net return on invested capital in this matter of close to 250%. The matter enjoyed a large favorable jury verdict in 2010 (along with a settlement with a secondary defendant in 2010 on account of which Burford received a $4 million cash payment) and a settlement in 2011 which caused assets to be conveyed to the plaintiff and Burford's recognition of further income in 2011. In 2012, Burford's interest in the land in issue was converted to a secured debt instrument with a current face value of a further $15.5 million; that mortgage bears interest running at a blended rate of 23% and has an ultimate face value of $50 million at maturity in 2016, although earlier payment is expected.

 

Burford will provide further commentary on the investment portfolio in its annual report but it remains very pleased with the performance of the portfolio and its future prospects.

 

Firstassist performance 3

 

Since Burford completed the acquisition of Firstassist on 29 February 2012, it has performed above budget and generated more than $11 million in EBITDA. Indeed, for the full fiscal year, Firstassist generated more than $14 million in EBITDA, an increase of more than 35% over the prior year. In addition to growing its leading litigation expenses insurance business, Firstassist launched a UK litigation funding business in 2012 and embarked on a series of initiatives to prepare itself and its clients for the implementation of the Jackson reforms in April 2013.

 

The strength of Firstassist's performance to date and the size of its pool of pending cases made it likely that the earn-out provided for at the time of Burford's acquisition of Firstassist would be payable. Thus, Burford negotiated an early payment of the earn-out in exchange for a substantial discount - more than $2 million - and therefore now owns Firstassist outright with no contingent future payments and no minority shareholders.

 

Burford is soon to receive a dividend from the cash generated by Firstassist's operations to date in an amount in excess of $11 million.

 

Clearly, the Firstassist acquisition has been an unqualified financial success in addition to the substantial strategic benefits it has brought to Burford.

 

Other income performance

 

Burford's cash management and litigation portfolio advances activities produced income of approximately $9 million in 2012. That income covered a significant part of Burford's operating expenses.

 

Capital commitment and deployment

 

Since inception, Burford has committed $373 million of capital to 46 investments:

 

Commitment Amount ($mm)

Number of Investments

Short duration portfolio

64

13

Core portfolio

223

28

Special situations portfolio

27

3

Other investments

59

2

Total

373

46

 

At 31 December 2012, Burford's outstanding commitments were as follows:

 

Commitment Amount ($mm)

Number of Investments

Short duration portfolio

27

5

Core portfolio

195

21

Special situations portfolio

9

2

Other investments

59

2

Total

289

30

 

During 2012, Burford continued actively to make new investments, and committed $72 million to nine new investments. Burford expects to continue actively investing in 2013. Burford is experiencing regular turnover in the portfolio as well as meaningful earnings from non-portfolio sources, freeing up previous commitments to reinvest.

 

Stand-by capital

 

As we informed shareholders in November, Burford is presently exploring an innovative stand-by capital arrangement. The Company does not intend to draw on such a facility as a source of operating leverage but views it as a conservative precaution to address the potential for uncertainty in the timing and funding of investments. Burford continues to consult shareholders on both the structure and ultimate adoption of such a facility, and there can be no guarantee that one will be finalised.

 

1 This information has not been audited or otherwise reviewed by the Company's auditors and is presented using non-IFRS measures. The Company disclaims any obligation to update, amend or correct this information.

2 Burford is beginning here the use of the term "investment recoveries". We use that term to encompass: (i) entirely concluded investments where Burford has received all proceeds to which it is entitled (net of any entirely concluded investment losses); (ii) investments where Burford has received some proceeds (for example, from a settlement with one party in a multi-party case) but where the investment is continuing with the possibility of receiving additional proceeds; and (iii) investments where the underlying litigation has been resolved and there is a promise to pay proceeds in the future (for example, in a settlement that is to be paid over time) and there is no longer any litigation risk involved in the investment. When we express returns, we do so assuming all investment recoveries are paid currently, discounting back future payments as appropriate. We do not include wins or other successes where there remains litigation risk in the definition of "investment recoveries"; we report those separately as pending matters.

3 Financial results provided here for Firstassist are based on unaudited management reporting prepared shortly after yearend and remain subject to further change and adjustment.

 

Release of annual results

 

Burford plans to release its audited financial statements and accompanying report and commentary on 11 April 2013. We will provide further details about the investment portfolio's performance and composition at that time.

 

For further information, please contact:

 

Burford Capital

Elizabeth O'Connell +1 212 235 6825

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

 

Espirito Santo Investment Bank - Joint Broker

Richard Crawley +44 (0)20 7456 9191

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0) 20 7653 4000

James Kelly

 

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 7269 7297

Laura Ewart +44 (0)20 7269 7243

 

About Burford

 

Burford is the world's largest provider of investment capital and risk solutions for litigation with more than $300 million in capital and the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world. 

 

For more information about Burford: www.burfordcapital.com.

 

 

 

 

This document does not constitute an offer of securities for sale in the United States or in any other jurisdiction. The securities mentioned in this document may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended. There is no intention to register securities, or any offering or placement thereof, in the United States or to conduct a public offering of securities in the United States. The Company has not been registered under the United States Investment Company Act of 1940, as amended.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEANFDAFFDEFF
Date   Source Headline
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.